Particle-facilitated pesticide leaching from differently structured soil monoliths.

The leaching of soil particles and surface applied 14C-labeled glyphosate and pendimethalin from intact soil columns (height: 50 cm; diameter: 30 cm) were investigated, and the relative significance of particle-facilitated pesticide transport was quantified. Investigations were performed with a recently plowed (four columns) and an untilled (five columns) sandy loam soil. Leaching was driven by three irrigation events (15 mm h(-1); 2 h each). Samples of the leachate were filtered immediately (within 1.5 minutes) using 20 nm filters, and the 14C-pesticide content was determined for filtered and unfiltered samples. Pesticide leaching was driven by preferential water flow in macropores. For the plowed structure, 68+/-10% of the leached glyphosate (average of 6 events+/-std.) was bound to particles whereas significantly less glyphosate was bound to particles in leachate from minimally disturbed columns (17+/-12%). Thus, the results suggest that soil structure affected the mode of transport of glyphosate. It is likely that glyphosate sorbed strongly when applied on recently plowed soil (Kd=503 L kg(-1) for the soil), and that it could be mobilized and transported independently of soil particles more easily when applied on the minimally disturbed soil covered in part with crop residues (Kd<1 L kg(-1) for straw). Significantly less amounts of soil particles were leached from minimally disturbed (119-247 mg) than from recently plowed (441-731 mg) columns. The significance of particle-facilitated pendimethalin leaching could not be accurately quantified due to disagreement between control measurements based on both 14C-activity and chemical analyses.

A magnetic bearing system for a continuous ventricular assist device.

This article describes a prototype continuous flow ventricular assist device (CFVAD3) supported in magnetic bearings. The VAD is a small centrifugal four bladed pump. The pump's geometry is explained. The CFVAD3 is the first compact VAD completely supported in magnetic bearings. The magnetic bearings are composed of an inlet side actuator divided into eight pole sets, and an outlet side actuator, also divided into eight pole sets. The pump operating performance was tested and found to be within the design flow rate of up to 9 L/min, and head up to 170 mm Hg for human circulatory support. Magnetic bearing operation out of center positions under various operating orientations were measured and found to be < 1/6 of the bearing clearance, well within specifications. The expected magnetic bearing power loss has been calculated at approximately 6.5 watts.

Inhibition of human insulin gene transcription by peroxisome proliferator-activated receptor gamma and thiazolidinedione oral antidiabetic drugs.

BACKGROUND AND PURPOSE: The transcription factor peroxisome proliferator-activated receptor gamma (PPARgamma) is essential for glucose homeostasis. PPARgamma ligands reducing insulin levels in vivo are used as drugs to treat type 2 diabetes mellitus. Genes regulated by PPARgamma have been found in several tissues including insulin-producing pancreatic islet beta-cells. However, the role of PPARgamma at the insulin gene was unknown. Therefore, the effect of PPARgamma and PPARgamma ligands like rosiglitazone on insulin gene transcription was investigated. EXPERIMENTAL APPROACH: Reporter gene assays were used in the beta-cell line HIT and in primary mature pancreatic islets of transgenic mice. Mapping studies and internal mutations were carried out to locate PPARgamma-responsive promoter regions. KEY RESULTS: Rosiglitazone caused a PPARgamma-dependent inhibition of insulin gene transcription in a beta-cell line. This inhibition was concentration-dependent and had an EC(50) similar to that for the activation of a reporter gene under the control of multimerized PPAR binding sites. Also in normal primary pancreatic islets of transgenic mice, known to express high levels of PPARgamma, rosiglitazone inhibited glucose-stimulated insulin gene transcription. Transactivation and mapping experiments suggest that, in contrast to the rat glucagon gene, the inhibition of the human insulin gene promoter by PPARgamma/rosiglitazone does not depend on promoter-bound Pax6 and is attributable to the proximal insulin gene promoter region around the transcription start site from -56 to +18. CONCLUSIONS AND IMPLICATIONS: The human insulin gene represents a novel PPARgamma target that may contribute to the action of thiazolidinediones in type 2 diabetes mellitus.

Comparison of the bioavailability of cyanocobalamin from capsule and liquid dosage forms.

Comparative in vivo absorption of cyanocobalamin from two dosage forms, gelatin capsule and liquid, was studied. Forty-two subjects received simultaneous doses of cyanocobalamin in capsule and liquid form, labeled with cobalt-57 and cobalt-60, respectively. Excretion, a measure of absorption, was between 2 percent and 66 percent greater with the liquid form. In vitro dissolution studies showed that the capsules had a tendency to collapse into a stringy mass and to dissolve slowly.